Patent ID: 7655397

Claim:
A method for diagnosing a particular type of cancer selected from the group consisting of rhabdomyosarcoma, Ewing's sarcoma, neuroblastoma and Burkitt's lymphoma comprising: i) comparing a first expression profile of a set of genes from a human cell sample to the expression profiles of the set of genes from a cell of each of said types of cancer; wherein said set of genes comprises at least the human genes IGF2, CCND1, GAS1, CNN3, FCGRT, a gene that comprises SEQ ID NO: 457, IGFBP2, GYG2, and a gene that comprises SEQ ID NO:462, wherein the first expression profile is obtained by detecting expression of IGF2, wherein IGF2 comprises the nucleic acid sequence of SEQ ID NO:72 or SEQ ID NO:73, of CCND1, wherein CCND1 comprises the nucleic acid sequence of SEQ ID NO:5, of GAS1, wherein GAS1 comprises the nucleic acid sequence of SEQ ID NO:59, of CNN3, wherein CNN3 comprises the nucleic acid sequence of SEQ ID NO:43, of FCGRT, wherein FCGRT comprises the nucleic acid sequence of SEQ ID NO:20, of a gene that comprises SEQ ID NO:457, wherein the gene comprises the nucleic acid sequence of SEQ ID NO:77, of IGFBP2, wherein IGFBP2 comprises the nucleic acid sequence of SEQ ID NO:28, of GYG2, wherein GYG2 comprises the nucleic acid sequence of SEQ ID NO:21, and of a gene that comprises SEQ ID NO:462, wherein the gene comprises the nucleic acid sequence of SEQ ID NO:26; and ii) identifying the human cell sample as one of rhabdomyosarcoma, Ewing's sarcoma, neuroblastoma or Burkitt's lymphoma based on the comparison of the first expression profile of the human cell sample to each of the expression profiles of rhabdomyosarcoma, Ewing's sarcoma, neuroblastoma and Burkitt's lymphoma.